1. Clark GW, Pope SM, Jaboori KA. Diagnosis and treatment of seborrheic dermatitis. Am Fam Physician. 2015;91(3):185-90. PMID: 25822272
2. Faergemann J. Management of seborrheic dermatitis and pityriasis versicolor. Am J Clin Dermatol. 2000;1(2):75-80. PMID: 11702314 DOI: 10.2165/00128071-200001020-00001
3. Gupta AK, Bluhm R, Cooper EA, Summerbell RC, Batra R. Seborrheic dermatitis. Dermatol Clin. 2003;21(3):401-12. PMID: 12956195 DOI: 10.1111/j.1468-3083.2004.00693.x
4. Gupta A, Bluhm R, Barlow J, Fleischer AB Jr, Feldman SR. Prescribing practices for seborrheic dermatitis vary with the physician's specialty: implications for clinical practice. J Dermatol Treat. 2004;15(4):208-13. PMID: 15764032 DOI: 10.1080/09546630410032430
5. Vincent SF, Casady M, Chacon A, Gaspari AA. Skin diseases in primary immunodeficiencies. Skin diseases in the immunosuppressed. New York: Springer; 2018. P. 35-51.
6. Gaitanis G, Magiatis P, Hantschke M, Bassukas ID, Velegraki A. The Malassezia genus in skin and systemic diseases. Clin Microbiol Rev. 2012;25(1):106-41. PMID: 22232373 DOI: 10.1128/CMR.00021-11
7. Viodé C, Lejeune O, Turlier V, Rouquier A, Casas C, Mengeaud V, et al. Cathepsin S, a new pruritus biomarker in clinical dandruff/seborrhoeic dermatitis evaluation. Exp Dermatol. 2014;23(4):274-5. PMID: 24690038 DOI: 10.1111/exd.12357
8. Schwartz JR, Messenger AG, Tosti A, Todd G, Hordinsky M, Hay RJ, et al. A comprehensive pathophysiology of dandruff and seborrheic dermatitis-towards a more precise definition of scalp health. Acta Derm Venereol. 2013;93(2):131-7. PMID: 22875203 DOI: 10.2340/00015555-1382
9. Burton JL, Rook A, Wilkinson DS. Eczema, lichen simplex, erythroderma and prurigo. Textbook of dermatology. Hoboken, NJ: Wiley-Blackwell Science; 2010. P. 29-34.
10. Imamoglu B, Hayta SB, Guner R, Akyol M, Ozcelik S. Metabolic syndrome may be an important comorbidity in patients with seborrheic dermatitis. Arch Med Sci Atheroscler Dis. 2016;1(1):e158-61. PMID: 28905039 DOI: 10.5114/amsad.2016.65075
11. Neimann AL, Shin DB, Wang X, Margolis DJ, Troxel AB, Gelfand JM. Prevalence of cardiovascular risk factors in patients with psoriasis. J Am Acad Dermatol. 2006;55(5):829-35. PMID: 17052489 DOI: 10.1016/j.jaad.2006.08.040
12. Meziane M, Kelati A, Najdi A, Berraho A, Nejjari C, Mernissi FZ. Metabolic syndrome in Moroccan patients with psoriasis. Int J Dermatol. 2016;55(4):396-400. PMID: 26712557 DOI: 10.1111/ijd.12623
13. Fröhlich M, Sund M, Löwel H, Imhof A, Hoffmeister A, Koenig W. Independent association of various smoking characteristics with markers of systemic inflammation in men: results from a representative sample of the general population (MONICA Augsburg Survey 1994/95). Eur Heart J. 2003;24(14):1365-72. PMID: 12871694 DOI: 10.1016/s0195-668x(03)00260-4
14. Hjelstuen A, Anderssen SA, Holme I, Seljeflot I, Klemsdal TO. Markers of inflammation are inversely related to physical activity and fitness in sedentary men with treated hypertension. Am J Hypertens. 2006;19(7):669-75. PMID: 16814119 DOI: 10.1016/j.amjhyper.2005.11.012
15. Lin CC, Kardia SL, Li CI, Liu CS, Lai MM, Lin WY, et al. The relationship of high sensitivity C-reactive protein to percent body fat mass, body mass index, waist-to-hip ratio, and waist circumference in a Taiwanese population. BMC Public Health. 2010;10(1):579. PMID: 20875142 DOI: 10.1186/1471-2458-10-579
16. Jung CH, Lee WY, Kim SY, Shin HS, Dai Kim H, Rhee EJ, et al. The risk of metabolic syndrome according to the high-sensitivity C-reactive protein in apparently healthy Koreans. Int J Cardiol. 2008;129(2):266-71. PMID: 17988754 DOI: 10.1016/j.ijcard.2007.07.092
17. Qureshi MM, Singer MR, Moore LL. A cross-sectional study of food group intake and C-reactive protein among children. Nutr Metab. 2009;6(1):40. PMID: 19822004 DOI: 10.1186/1743-7075-6-40
18. Ridker PM, Buring JE, Cook NR, Rifai N. C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14 719 initially healthy American women. Circulation. 2003;107(3):391-7. PMID: 12551861 DOI: 10.1161/01.cir.0000055014.62083.05
19. Lee WY, Park JS, Noh SY, Rhee EJ, Sung KC, Kim BS, et al. C-reactive protein concentrations are related to insulin resistance and metabolic syndrome as defined by the ATP III report. Int J Cardiol. 2004;97(1):101-6. PMID: 15336815 DOI: 10.1016/j.ijcard.2003.08.016
20. Tannock LR, O’brien KD, Knopp RH, Retzlaff B, Fish B, Wener MH, et al. Cholesterol feeding increases C-reactive protein and serum amyloid A levels in lean insulin-sensitive subjects. Circulation. 2005;111(23):3058-62. PMID: 15939816 DOI: 10.1161/CIRCULATIONAHA.104.506188
21. Poitou C, Coussieu C, Rouault C, Coupaye M, Cancello R, Bedel JF, et al. Serum amyloid A: a marker of adiposity‐induced low‐grade inflammation but not of metabolic status. Obesity. 2006;14(2):309-18. PMID: 16571858 DOI: 10.1038/oby.2006.40
22. Liu J, Young TK, Zinman B, Harris SB, Connelly PW, Hanley AJ. Lifestyle variables, non‐traditional cardiovascular risk factors, and the metabolic syndrome in an Aboriginal Canadian population. Obesity. 2006;14(3):500-8. PMID: 16648622 DOI: 10.1038/oby.2006.65
23. Zuliani G, Volpato S, Galvani M, Blè A, Bandinelli S, Corsi AM, et al. Elevated C-reactive protein levels and metabolic syndrome in the elderly: the role of central obesity: data from the Inchianti study. Atherosclerosis. 2009;203(2):626-32. PMID: 18845301 DOI: 10.1016/j.atherosclerosis.2008.07.038
24. Fizelova M, Jauhiainen R, Kangas AJ, Soininen P, Ala-Korpela M, Kuusisto J, et al. Differential associations of inflammatory markers with insulin sensitivity and secretion: the prospective METSIM study. J Clin Endocrinol Metab. 2017;102(9):3600-9. PMID: 28911155 DOI: 10.1210/jc.2017-01057
25. Borda LJ, Wikramanayake TC. Seborrheic dermatitis and dandruff: a comprehensive review. J Clin Invest Dermatol. 2015;3(2):1-22. PMID: 27148560 DOI: 10.13188/2373-1044.1000019
26. Berk T, Scheinfeld N. Seborrheic dermatitis. P T. 2010;35(6):348-52. PMID: 20592880
27. Newcomer JW. Metabolic syndrome and mental illness. Am J Manag Care. 2007;13(Suppl 7):S170-7. PMID: 18041878
28. Stefanadi EC, Dimitrakakis G, Antoniou CK, Challoumas D, Punjabi N, Dimitrakaki IA, et al. Metabolic syndrome and the skin: a more than superficial association. Reviewing the association between skin diseases and metabolic syndrome and a clinical decision algorithm for high risk patients. Diabetol Metab Syndr. 2018;10(1):9. PMID: 29483947 DOI: 10.1186/s13098-018-0311-z
29. Rodríguez-Zúñiga MJ, García-Perdomo HA. Systematic review and meta-analysis of the association between psoriasis and metabolic syndrome. J Am Acad Dermatol. 2017;77(4):657-66. PMID: 28917453 DOI: 10.1016/j.jaad.2017.04.1133
30. Ghaderi R, Kazemi T, Zarban A, Erfanian M. The relationship of plasma antioxidants and serum lipid levels with seborrheic dermatitis (SD): a case-control study. J Adv Med Biomed Res. 2007;15(60):83-92. [Persian]
31. Gordon SM, Hofmann S, Askew DS, Davidson WS. High density lipoprotein: it's not just about lipid transport anymore. Trends Endocrinol Metab. 2011;22(1):9-15. DOI: 10.1016/j.tem.2010.10.001
32. Ahima RS, Flier JS. Adipose tissue as an endocrine organ. Trends Endocrinol Metab. 2000;11(8):327-32. PMID: 10996528 DOI: 10.1016/s1043-2760(00)00301-5
33. Mirza MS. Obesity, visceral fat, and NAFLD: Querying the role of adipokines in the progression of nonalcoholic fatty liver disease. ISRN Gastroenterol. 2011;2011:592404. PMID: 21991518 DOI: 10.5402/2011/592404
34. Nakamizo S, Honda T, Kabashima K. Obesity and inflammatory skin diseases. Trends Immunother. 2017;1(2):67-74. DOI: 10.24294/ti.v1.i2.98
35. Shenoy C, Shenoy MM, Rao GK. Dyslipidemia in dermatological disorders. N AM J Med Sci. 2015;7(10):421-8. PMID: 26713286 DOI: 10.4103/1947-2714.168657
36. Linder D, Dreiher J, Zampetti A, Sampogna F, Cohen A. Seborrheic dermatitis and hypertension in adults: a cross‐sectional study. J Eur Acad Dermatol Venereol. 2014;28(11):1450-5. PMID: 24267636 DOI: 10.1111/jdv.12310